Prospective Observational Study of Implantable Cardioverter‐Defibrillators in Primary Prevention of Sudden Cardiac Death: Study Design and Cohort Description

Department of Medicine, Johns Hopkins University, Baltimore, MD.
Journal of the American Heart Association (Impact Factor: 4.31). 12/2013; 2(1):e000083. DOI: 10.1161/JAHA.112.000083
Source: PubMed


Primary-prevention implantable cardioverter-defibrillators (ICDs) reduce total mortality in patients with severe left ventricular systolic function. However, only a minority of patients benefit from these devices. We designed the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD) to identify risk factors and enhance our understanding of the biological mechanisms that predispose to arrhythmic death in patients undergoing ICD implantation for primary prevention of sudden death.
This is a multicenter prospective cohort study with a target enrollment of 1200 patients. The primary end point is ICD shocks for adjudicated ventricular tachyarrhythmias. The secondary end point is total mortality. All patients undergo a comprehensive evaluation including history and physical examination, signal-averaged electrocardiograms, and blood sampling for genomic, proteomic, and metabolomic analyses. Patients are evaluated every 6 months and after every known ICD shock for additional electrocardiographic and blood sampling. As of December 2011, a total of 1177 patients have been enrolled with more nonwhite and female patients compared to previous randomized trials. A total of 143 patients have reached the primary end point, whereas a total of 260 patients died over an average follow-up of 59 months. The PROSE-ICD study represents a real-world cohort of individuals with systolic heart failure receiving primary-prevention ICDs.
Extensive electrophysiological and structural phenotyping as well as the availability of serial DNA and serum samples will be important resources for evaluating novel metrics for risk stratification and identifying patients at risk for arrhythmic sudden death.
URL: Unique Identifier: NCT00733590.

Download full-text


Available from: Eliseo Guallar, Jun 29, 2014
37 Reads
  • Source
    Journal of the American Heart Association 08/2013; 2(5):e000541. DOI:10.1161/JAHA.113.000541 · 4.31 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sudden Cardiac Arrest (SCA) is a devastating heart abnormality which leads to millions of casualty per year. Thus, early detection or prediction of SCA could save the human lives in greater scale. This present work is aimed to predict SCA two minutes before its occurrence and significant results has been obtained using the proposed signal processing methodology. Two international standard databases namely, MIT/BIH Sudden Cardiac Death (SCD) Holter Database for SCA and Physiobank Normal Sinus Rhythm (NSR) for normal control data were used in this work. Initially, five minutes R-R interval of a subject which is two minutes before the onset of SCA was extracted from MIT/BIH database’s annotation files for predicting the SCA. Then, Heart Rate Variability (HRV) signal was pre-processed for ectopic beats removal and detrending using mean and discrete wavelet transform (DWT) respectively. Pre-processed HRV was analysed in time, frequency and nonlinear domains to extract various features to efficiently predict SCA. Totally, 34 features (15 time domain, 13 frequency domains, and 6 nonlinear domains) were extracted from each HRV signal samples of normal and SCA subjects. Sequential Feature Selection (SFS) algorithm is used to select optimal features and seven features (2 time, 3 frequency and 2 nonlinear) among 34 features was chosen as a result. Finally, Support Vector Machine (SVM) and Probabilistic Neural Network (PNN) were used to predict the SCA and normal control cases. SVM and PNN give maximum mean SCA prediction rate of 96.36% and 93.64% respectively. Thus the present experimental results clearly indicates that, SVM classifier is more efficient in predicting SCA than PNN and mean classification rate reported in this work is higher compared to the earlier works on predicting SCA.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Implantable cardioverter defibrillators (ICDs) reduce the risk of death in patients with left ventricular dysfunction. Little is known regarding the benefit of this therapy in African-Americans (AA). To determine the association between African-American race and outcomes in a cohort of primary prevention cardioverter defibrillators (ICD) patients. We conducted a prospective cohort study of patients with systolic heart failure who underwent ICD implantation for primary prevention of sudden cardiac death. The primary endpoint was appropriate ICD shock defined as a shock for rapid ventricular tachyarrhythmias. The secondary endpoint was all-cause mortality. There were 1,189 patients (447 AAs and 712 non-AAs) enrolled. Over a median follow-up of 5.1 years, a total of 137 patients experienced an appropriate ICD shock, and 343 died (294 of whom died without receiving an appropriate ICD shock). The multivariate adjusted hazard ratios (95% CI) comparing AAs vs. non-AAs were 1.24 (0.96 to 1.59) for all-cause mortality, 1.33 (1.02, 1.74) for all-cause mortality without receiving appropriate ICD shock, and 0.78 (0.51, 1.19) for appropriate ICD shock. Ejection fraction, diabetes, and hypertension appeared to explain 24.1% (10.1 to 69.5%), 18.7% (5.3 to 58.0%), and 13.6% (3.8 to 53.6%) of the excess risk of mortality in AAs, with a large proportion of the mortality difference remains unexplained. In patients with primary prevention ICDs, AAs had an increased risk of dying without receiving an appropriate ICD shock compared to non-AAs.
    Heart rhythm: the official journal of the Heart Rhythm Society 04/2014; 11(8). DOI:10.1016/j.hrthm.2014.04.039 · 5.08 Impact Factor
Show more